A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1 percent more people leaving hospital alive — but almost doubles the risk of severe brain damage for survivors of cardiac arrest. The research raises important questions about the future use of adrenaline in such cases and will necessitate debate amongst healthcare professionals, patients and the public.